Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.74 EUR | +2.49% | +4.75% | -6.36% |
04-26 | ResMed tops quarterly profit estimates on strong demand for sleep apnea devices | RE |
04-23 | PHILIPS NV : Jefferies reiterates its Sell rating | ZD |
Evolution of the average Target Price on Philips NV
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Philips NV
JEFFERIES | Julien Dormois |
HSBC | |
alphavalue | Anas Patel |
BARCLAYS | Hassan Al-Wakeel |
DEUTSCHE BANK RESEARCH | Falko Friedrichs |
JPMORGAN | David Adlington |
UBS | Graham Doyle |
BERNSTEIN RESEARCH | Lisa Bedell Clive |
DZ BANK | Elmar Kraus |
MORGAN STANLEY | Robert Davies |
GOLDMAN SACHS | Richard Felton |
Jefferies & Co. | |
Societe Generale | |
JPMorgan Chase | |
Credit Suisse | |
DEUTSCHE BANK | Falko Friedrichs |
KEPLER CHEUVREUX | Oliver Reinberg |
Citigroup | |
BERENBERG | Scott Bardo |
ING Group | |
Deutsche Bank Securities | |
J.P. Morgan Chase |
EPS Revisions
- Stock Market
- Equities
- PHIA Stock
- Consensus Philips NV